» Authors » Joana Damasio

Joana Damasio

Explore the profile of Joana Damasio including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 67
Citations 349
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Damasio J, Costa S, Moura J, Santos M, Lemos C, Mendes A, et al.
Mov Disord Clin Pract . 2025 Feb; PMID: 39936868
Background: Hereditary cerebellar ataxia (HCA) represents a complex group of disorders, with a wide spectrum of neurological symptoms. Among these, non-ataxia movement disorders (MD) have been increasingly acknowledged, with variable...
2.
Vale T, Santos D, Oliveira D, Brandao P, Pereira D, Bouca-Machado R, et al.
Parkinsonism Relat Disord . 2025 Jan; 132:107276. PMID: 39848139
Background: The Movement Disorder Society Non-Motor Rating Scale (MDS-NMS) serves as a comprehensive clinical assessment tool for non-motor symptoms in Parkinson's disease (PD) OBJECTIVES: This study aims to validate the...
3.
Moura J, Lopes J, Freitas C, Samoes R, Damasio J
Parkinsonism Relat Disord . 2024 Nov; 129:107187. PMID: 39489101
No abstract available.
4.
Moura J, Oliveira J, Santos M, Costa S, Silva L, Lemos C, et al.
Cerebellum . 2024 Jul; 23(6):2258-2268. PMID: 39048885
Spinocerebellar ataxias (SCA) are most frequently due to (CAG) (coding for polyglutamine, polyQ) expansions and, less so, to expansion of other oligonucleotide repeats (non-polyQ) or other type of variants (non-repeat...
5.
Moura J, Malaquias M, Jorge F, Pinto E, Sardoeira A, Laranjinha I, et al.
Acta Med Port . 2024 Apr; 37(6):429-435. PMID: 38669036
Introduction: Neurological involvement in immunoglobulin G4-related disease (IgG4-RD) is increasingly recognized. Its diagnosis can be challenging due to clinical mimics and difficulty in obtaining nervous system biopsies. The aim of...
6.
Goncalves A, Mendes A, Damasio J, Vila-Cha N, Boleixa D, Leal B, et al.
J Parkinsons Dis . 2024 Feb; 14(2):313-324. PMID: 38363619
Background: A possible genetic contribution of dopamine D3 receptor (DRD3) to cognitive impairment in Parkinson's disease (PD) has yet to be investigated. Objective: To explore the effects of rs6280 (Ser9Gly)...
7.
Silva L, Freixo J, Brandao A, Cardoso M, Damasio J
Mov Disord Clin Pract . 2023 Oct; 10(10):1566-1567. PMID: 37868919
No abstract available.
8.
Moura J, Samoes R, Cardoso M, Sousa A, Damasio J, Marinho A, et al.
Clin Neurol Neurosurg . 2023 Oct; 234:107994. PMID: 37797365
Introduction: Anti-contactin-associated protein-like 2 (CASPR2) is classically associated with limbic encephalitis (LE), Morvan syndrome and peripheral nerve hyperexcitability (PNH). Additional clinical features have been previously recognized. Objective: To describe a...
9.
Vollstedt E, Madoev H, Aasly A, Ahmad-Annuar A, Al-Mubarak B, Alcalay R, et al.
PLoS One . 2023 Oct; 18(10):e0292180. PMID: 37788254
Parkinson's disease (PD) is the fastest-growing neurodegenerative disorder, currently affecting ~7 million people worldwide. PD is clinically and genetically heterogeneous, with at least 10% of all cases explained by a...
10.
Malaquias M, Braz L, Santos Silva C, Damasio J, Jorge A, Lemos J, et al.
Neurol Clin Pract . 2023 Sep; 13(5):e200190. PMID: 37674869
Background And Objectives: The spectrum has become considerably expanded as multisystemic features beyond the triad of cerebellar ataxia, neuropathy, and vestibular areflexia syndrome (CANVAS) have started to be unveiled, although...